Seelos Therapeutics Stock Total Asset
Seelos Therapeutics fundamentals help investors to digest information that contributes to Seelos Therapeutics' financial success or failures. It also enables traders to predict the movement of Seelos OTC Stock. The fundamental analysis module provides a way to measure Seelos Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Seelos Therapeutics otc stock.
Seelos |
Seelos Therapeutics OTC Stock Total Asset Analysis
Seelos Therapeutics' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Seelos Therapeutics Total Asset | 5.42 M |
Most of Seelos Therapeutics' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Seelos Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Seelos Therapeutics has a Total Asset of 5.42 M. This is 99.93% lower than that of the Pharmaceuticals sector and 99.73% lower than that of the Health Care industry. The total asset for all United States stocks is 99.98% higher than that of the company.
Seelos Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Seelos Therapeutics' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Seelos Therapeutics could also be used in its relative valuation, which is a method of valuing Seelos Therapeutics by comparing valuation metrics of similar companies.Seelos Therapeutics is currently under evaluation in total asset category among its peers.
Seelos Fundamentals
Return On Equity | -5.84 | |||
Return On Asset | -2.61 | |||
Profit Margin | 2.03 % | |||
Operating Margin | (8.35) % | |||
Current Valuation | 10.45 M | |||
Shares Outstanding | 581 K | |||
Shares Owned By Insiders | 0.49 % | |||
Shares Owned By Institutions | 4.46 % | |||
Number Of Shares Shorted | 170.89 K | |||
Price To Book | 15.10 X | |||
Price To Sales | 0.37 X | |||
Revenue | 2.2 M | |||
Gross Profit | (46.65 M) | |||
EBITDA | (40.44 M) | |||
Net Income | (37.88 M) | |||
Cash And Equivalents | 41.25 M | |||
Cash Per Share | 0.39 X | |||
Total Debt | 14.23 M | |||
Debt To Equity | 0.73 % | |||
Current Ratio | 3.60 X | |||
Book Value Per Share | (135.50) X | |||
Cash Flow From Operations | (23.91 M) | |||
Short Ratio | 0.14 X | |||
Earnings Per Share | 351.04 X | |||
Target Price | 120.0 | |||
Beta | 1.85 | |||
Market Capitalization | 743.68 K | |||
Total Asset | 5.42 M | |||
Retained Earnings | (252.63 M) | |||
Working Capital | (33.52 M) | |||
Net Asset | 5.42 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in income. Note that the Seelos Therapeutics information on this page should be used as a complementary analysis to other Seelos Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Seelos OTC Stock
If you are still planning to invest in Seelos Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Seelos Therapeutics' history and understand the potential risks before investing.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |